HighLight Capital
Overview
HighLight Capital is a private investment firm founded in 2014 that focuses on the healthcare, biotech, and consumer sectors, with an emphasis on promoting technology innovations.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Abogen Biosciences | Aug 2021 | Series C | Co-investor |
| Infinigence AI | Nov 2025 | Series A Extension | Co-investor |
| Xingyun Group | Apr 2021 | Series C Extension | Co-investor |
| Pudu Robotics | Apr 2026 | Series D | Co-investor |
| Approaching.AI | Jul 2026 | Series A | Co-investor |
For institutional investors. Book with your work email.
Key People
Bruce X.
Partner Co-Founder
Chen Bing
Partner
Xing He
Partner
Runxie L.
Principal
Zimou Michael W.
Healthcare Investor
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is HighLight Capital based?
HighLight Capital is headquartered in Shanghai, Shanghai, China.
When was HighLight Capital founded?
HighLight Capital was founded in 2014.
How many portfolio companies does HighLight Capital have?
HighLight Capital has 51 portfolio companies in Caplight's dataset.
What are some companies in HighLight Capital's portfolio?
Portfolio companies visible on Caplight include Abogen Biosciences, Infinigence AI, Xingyun Group, Pudu Robotics, Approaching.AI.
What was HighLight Capital's most recent investment shown here?
HighLight Capital's most recent investment in this portfolio sample was in Approaching.AI in 2026.
What sectors does HighLight Capital focus on?
HighLight Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Crypto & Web3, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Frontier & Industrial Tech, Consumer & Commerce, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Frontier & Industrial Tech, FinTech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Mobility, Transportation & Logistics, Consumer & Commerce, Mobility, Transportation & Logistics, Enterprise Software, Frontier & Industrial Tech, Enterprise Software, Mobility, Transportation & Logistics, Mobility, Transportation & Logistics, Energy & Sustainability, Enterprise Software, Mobility, Transportation & Logistics, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, FinTech, AI, Data & Cloud Infrastructure, Consumer & Commerce, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does HighLight Capital focus on?
HighLight Capital typically invests at the MultiStage stage.
What is HighLight Capital's AUM?
HighLight Capital's assets under management are estimated between $3.8B and $4.0B.